Kriya Therapeutics, Inc.

Next-generation gene therapy company

Kriya was founded in early 2020 by Shankar Ramaswamy, Roger Jeffs and Fraser Wright, as a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases. Kriya targets conditions where the underlying biology is well-understood, rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate human tissues. The team has deep expertise in the field and includes former senior leadership from pioneering gene therapy companies and academic institutions. The company uses algorithmic tools, scalable infrastructure, and proprietary technology to optimize the efficacy and durability of their gene therapies – with a goal of transforming the treatment paradigm for some of the most serious and widespread diseases.